EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Emerging Role of FAM171A2 in Gynecological Malignancies: Bioinformatic Insights from UCEC and Ovarian Cancer

Sibel Soylemez, Durmus Ayan

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms262211126 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Sibel Soylemez und 1 weiteren Autor:innen. Beteiligte Einrichtung: Gazi University Life Sciences Application and Research Center, Ankara 06560, Türkiye. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Computational Biology, Endometrial Neoplasms, Neoplasm Proteins. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The FAM171A2 gene encodes a transmembrane protein that is not well characterized but is implicated in signaling, vesicle trafficking, and interactions with the extracellular matrix. Its specific role in gynecologic malignancies has yet to be defined. To our knowledge, this is the first systematic study to comprehensively assess FAM171A2 expression, clinical relevance, and molecular network interactions in gynecologic malignancies. We employed an integrative approach utilizing multi-platform transcriptomic and proteomic resources—GEPIA2, TNMplot, TIMER2, UALCAN, KM-plotter, Human Protein Atlas (HPA), Gene Expression Omnibus (GEO), STRING, TargetScan, and ENCORI—to comprehensively profile FAM171A2 expression, its clinicopathologic correlations, survival associations, predicted interaction networks, and post-transcriptional regulation in ovarian cancer (OV) and uterine corpus endometrial carcinoma (UCEC). Immunohistochemical analysis from the HPA indicated low or undetectable levels of the FAM171A2 protein in OV and UCEC. In contrast, RNA sequencing analyses demonstrated upregulated mRNA expression in OV and a modest, non-significant increase in UCEC compared to normal tissues. Pan-cancer screening using TNMplot and TIMER2 revealed elevated expression in gynecologic tumors relative to most other cancer types. In OV, UALCAN analysis identified associations with demographic and molecular characteristics, such as increased expression in TP53-mutant tumors, while trends related to stage and grade were minimal. Similarly, stratifications in UCEC suggested modulation by race, body mass index (BMI), and menopausal status rather than stage. Survival analyses using KM-plotter showed no significant association with overall survival in either type of cancer. TargetScan predicted 211 microRNAs potentially targeting FAM171A2, and ENCORI correlations supported tumor-type-specific post-transcriptional regulation: in OV, negative correlations were observed with miR-15b-5p, miR-16-5p, and miR-497-5p, along with long non-coding RNA (lncRNA) effects, including positive correlations with BACE1-AS and negative correlations with PVT1 and UCA1. In UCEC, significant negative correlations were found with LINC00582, LINC-ROR, MEG3, NEAT1, and SNHG12. STRING network analysis suggested two modules associated with FAM171A2: a neuronal/synaptic cluster, exemplified by NPTX1, and an immune/transcriptional cluster, exemplified by ZNF696. Validation using the GEO showed mixed results: two UCEC datasets were non-significant, whereas one OV cohort (GSE36368) exhibited higher tumor expression. FAM171A2 demonstrates context-dependent expressions that are modulated post-transcriptionally in gynecologic cancers. While it is not independently prognostic, it may serve as a molecular hub at the intersection of neuronal and immune pathways, warranting further mechanistic investigations and exploration as a panel-based biomarker.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ovarian NeoplasmsComputational BiologyEndometrial NeoplasmsNeoplasm ProteinsMembrane ProteinsHumansFemaleGene Expression Regulation, NeoplasticBiomarkers, TumorGene Expression ProfilingGene Regulatory Networks

Stichwörter der Autor:innen

FAM171A2 gene expressionbioinformatics and multi-omics analysisextracellular vesicle biologygynecologic neoplasmsmicroRNA–lncRNA interaction networkovarian serous cystadenocarcinomapost-transcriptional gene regulationtransmembrane signaling proteinstumor microenvironment modulationuterine corpus endometrial carcinoma (UCEC)

Substanzen

Biomarkers, TumorNeoplasm ProteinsMembrane Proteins

Autor:innen und Institutionen

  • Gazi University Life Sciences Application and Research Center, Ankara 06560, Türkiye.
  • Medical Laboratory Techniques Program, Department of Medical Services and Techniques, Gazi University Vocational School of Health Services, Ankara 06560, Türkiye.
  • Medical Biochemistry, Faculty of Medicine, Nigde Omer Halisdemir University, Nigde 51200, Türkiye.
  • Medical Biochemistry, Nigde Omer Halisdemir University Research and Training Hospital, Nigde 51200, Türkiye.

Zitieren

APA

Soylemez, S., & Ayan, D. (2025). The Emerging Role of FAM171A2 in Gynecological Malignancies: Bioinformatic Insights from UCEC and Ovarian Cancer. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262211126

Vancouver

Soylemez S, Ayan D. The Emerging Role of FAM171A2 in Gynecological Malignancies: Bioinformatic Insights from UCEC and Ovarian Cancer. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262211126

BibTeX
@article{Soylemez2025,
  author = {Soylemez, Sibel and Ayan, Durmus},
  title = {The Emerging Role of FAM171A2 in Gynecological Malignancies: Bioinformatic Insights from UCEC and Ovarian Cancer},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms262211126}
}
Kostenlos starten →